-
Type:
Change Request
-
Resolution: Persuasive
-
Priority:
Medium
-
FHIR Core (FHIR)
-
R5
-
Biomedical Research & Regulation
-
SubstanceDefinition
-
-
Norman Gregory/Catherine Hosage Norman: 19-0-0
-
Clarification
-
Non-substantive
-
R5
Request to change the definition of SubstanceDefinition.Representation.type to accommodate the FDA PQ/CMC requirement of supporting the methods used for substance characterization in eCTD M3.
Change definition —
FROM: The type of structure (e.g. Full, Partial, Representative).
TO: The kind of representation (e.g. full, partial) or the technique used to derive the analytical characterization of the substance (e.g. x-ray, HPLC, NMR, peptide mapping, ligand binding assay, etc.).